US13463J1016
US13463J1016
CAMP4 THERAPEUTICS CORPORATION
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 3.498.000 | 652.000 | 436.5% |
| Cost of Revenue | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| 55.559.000 | 53.740.000 | 3.4% | |
| Operating Income | -52.061.000 | -53.088.000 | 1.9% |
| Pretax Income | -80.403.000 | -51.791.000 | 55.2% |
| Net Income Common Stockholders | -80.403.000 | -51.791.000 | 55.2% |
| -- | -- | -- | |
| -- | -- | -- |